BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15740732)

  • 21. [Mechanism of reduction in proteinuria by cyclosporine A: effects on the glomerular anionic sites].
    Tanabe T
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):377-83. PubMed ID: 2227790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary kallikrein in experimental renal disease.
    Glasser RJ; Michael AF
    Lab Invest; 1976 Jun; 34(6):616-22. PubMed ID: 933467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse effect of indomethacin in experimental chronic nephrosis.
    Kleinknecht C; Laouari D; Gubler MC; Gros F
    Int J Pediatr Nephrol; 1983 Jun; 4(2):83-8. PubMed ID: 6618773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T; Kaneko K; Yamada T; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1430-4. PubMed ID: 16079985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine profoundly suppresses excitatory transmission in neonatal rat hippocampus via phosphatidylinositol-linked D1-like receptor.
    Noriyama Y; Ogawa Y; Yoshino H; Yamashita M; Kishimoto T
    Neuroscience; 2006; 138(2):475-85. PubMed ID: 16406680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
    Zhu Y; Lu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
    Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
    Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
    Abboud HE; Ou SL; Velosa JA; Shah SV; Dousa TP
    J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glycyrrhetinic acid on aminonucleoside nephrosis in rats.
    Guoji Y; Orita M; Tashiro K; Abe H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):318-23. PubMed ID: 8208309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis.
    Whiteside CI; Cameron R; Munk S; Levy J
    Am J Pathol; 1993 May; 142(5):1641-53. PubMed ID: 8494056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    Ren Physiol; 1986; 9(6):366-74. PubMed ID: 3602582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
    Yayama K; Kawao M; Tujii H; Itoh N; Okamoto H
    Eur J Pharmacol; 1993 May; 236(2):337-8. PubMed ID: 8319760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis.
    Egashira Y; Nagaki S; Sanada H
    Int J Vitam Nutr Res; 2006 Jan; 76(1):28-33. PubMed ID: 16711654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.